Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study

被引:6
|
作者
Huang, Guang-Ming [1 ]
Qiu, Yue [1 ]
Liu, Tao-Tao [1 ]
Lu, Jie-Jiu [1 ]
机构
[1] Guangxi Med Univ, Dept Pharm, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
基金
中国国家自然科学基金;
关键词
augmented renal clearance; critically ill infant; normal renal function; population pharmacokinetics; vancomycin; STAPHYLOCOCCUS-AUREUS INFECTIONS; PEDIATRIC-PATIENTS; TROUGH CONCENTRATIONS; FEBRILE NEUTROPENIA; CYTOKINES; EXPOSURE; CHILDREN; OUTCOMES;
D O I
10.1002/jcph.2029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Augmented renal clearance presents as super-renal function with enhanced renal perfusion and glomerular hyperfiltration in many critically ill infants. This study was to compare vancomycin clearance (CL) between critically ill infants with augmented renal clearance and with normal renal function and to optimize the vancomycin dosage. Data were retrospectively obtained from infants treated in intensive care units. Population pharmacokinetics analysis was conducted using nonlinear mixed-effects model software. A total of 66 critically ill infants were included: 47 infants with augmented renal clearance and 19 infants with normal renal function. The median doses of vancomycin for infants with augmented renal clearance and with normal renal function were 48 and 47 mg/kg/day (P > .05), respectively. The median CL in infants with augmented renal clearance was increased 1.96-fold compared with infants who had normal renal function (0.98 versus 0.5 L/h, P < .001). Simulations indicated that the recommended dosage of 60, 70, 80, 90, and 100 mg/kg/day would be appropriate in critically ill infants with an estimated glomerular filtration rate (eGFR) of 130-149, 150-169, 170-189, 190-209, and >210 mL/min/1.73 m(2), respectively. Doses of 70 and 75 mg/kg/day were recommended for infants with augmented renal clearance and gestational ages of 27-32.9 and 33-39 weeks, respectively. Doses of 70, 75, 80, and 90 mg/kg/day were recommended for infants with augmented renal clearance and weights of 2.0-2.9, 3.0-3.9, 4.0-4.9, and 5.0-6.0 kg, respectively. In conclusion, the typical vancomycin dosage is insufficient for critically ill infants with augmented renal clearance. Premature infants and infants of low weight with augmented renal clearance need individualized dosing regimens to obtain an adequate area under the serum concentration time curve over 24 h/minimum inhibitory concentration ratio.
引用
收藏
页码:863 / 872
页数:10
相关论文
共 50 条
  • [1] Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
    Chu, Yang
    Luo, Yifan
    Ji, Shuangmin
    Jiang, Mingyan
    Zhou, Baosen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 68 - 74
  • [2] The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients
    Tesfamariam, Novel Solomon
    Aboelezz, Asma
    Mahmoud, Sherif Hanafy
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [3] Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance
    He, Cui-Yao
    Ye, Pan-Pan
    Liu, Bin
    Song, Lin
    van den Anker, John
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [4] Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function
    Li, De-Yi
    Li, Ling
    Li, Gui-Zhou
    Hu, Ya-Hui
    Guo, Hong-Li
    Jing, Xia
    Chen, Feng
    Ji, Xing
    Xu, Jing
    Dai, Hao-Ran
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [5] Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children
    Lv, Chun-Le
    Lu, Jie-Jiu
    Chen, Ming
    Zhang, Ren
    Li, Qiao-Chuan
    Chen, Yi-Yu
    Liu, Tao-Tao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1278 - 1287
  • [6] Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance
    Hirai, Keita
    Ihara, Setsuko
    Kinae, Ayumi
    Ikegaya, Kenichi
    Suzuki, Masayuki
    Hirano, Keiko
    Itoh, Kunihiko
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 393 - 397
  • [7] Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children
    Dhont, Evelyn
    Van der Heggen, Tatjana
    Snauwaert, Evelien
    Willems, Jef
    Croubels, Siska
    Delanghe, Joris
    De Waele, Jan J.
    Colman, Roos
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter A.
    PEDIATRIC NEPHROLOGY, 2024, 39 (05) : 1607 - 1616
  • [8] A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
    He, Juan
    Yang, Zhi-Tao
    Qian, Xian
    Zhao, Bing
    Mao, En-Qiang
    Chen, Er-Zhen
    Bian, Xiao-Lan
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2166 - 2171
  • [9] Drug Utilization in Critically Ill Adults with Augmented Renal Clearance Compared to Normal Renal Clearance: Implications for use of Anti-microbials with Predominant Renal Excretion
    Sridharan, Kannan
    Pasha, Sheikh A. A.
    Qader, Ali M.
    Hasan, Hasan M. S. N.
    El Seirafi, Mohamed M.
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (02) : 174 - 181
  • [10] Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance
    Nicolau, David P.
    De Waele, Jan
    Kuti, Joseph L.
    Caro, Luzelena
    Larson, Kajal B.
    Yu, Brian
    Gadzicki, Elaine
    Zeng, Zhen
    Rhee, Elizabeth G.
    Rizk, Matthew L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (04)